1. Rossix AB, Mölndal, Sweden;
2. Colorado Coagulation, Laboratory Corporation of America Holdings, Englewood, CO;
3. BioMarin Pharmaceutical Inc, Novato, CA;
4. Royal London Haemophilia Centre, Barts Health, National Health Service (NHS) Trust, London, United Kingdom;
5. University Hospital Southampton, Southampton, United Kingdom;
6. Cambridge University Hospitals, NHS Foundation Trust, Cambridge, United Kingdom;
7. Division of Hematology/Oncology, Department of Medicine, University of California at Davis, Sacramento, CA; and
8. Independent Consultant